Novo Nordisk Launches $149 Wegovy Pill, Expanding Access to GLP-1 Weight-Loss Drugs

The once-daily Wegovy pill became the first oral GLP-1 approved for weight loss in the U.S., offering an alternative to injectable treatments that have driven soaring demand.